β-Blockers in Myocardial Infarction: Issues With Standard Admission Order Sets

JAMA. 2018 Mar 27;319(12):1269-1270. doi: 10.1001/jama.2018.0845.

Authors

Arjun Gupta¹, Sandeep R Das^{1

2}, Ambarish Pandey^{1

2}

Affiliations

¹ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
² Division of Cardiology, University of Texas Southwestern Medical Center, Dallas.

PMID: 29584845
DOI: 10.1001/jama.2018.0845

No abstract available

Publication types

Case Reports

MeSH terms

Adrenergic beta-Antagonists / adverse effects*
Adrenergic beta-Antagonists / therapeutic use
Carbazoles / adverse effects*
Carbazoles / therapeutic use
Carvedilol
Contraindications, Drug*
Electrocardiography
Heart Block / diagnosis
Heart Block / etiology
Heart Failure / etiology*
Humans
Male
Medication Errors
Middle Aged
Patient Admission
Percutaneous Coronary Intervention*
Practice Guidelines as Topic*
Propanolamines / adverse effects*
Propanolamines / therapeutic use
ST Elevation Myocardial Infarction / complications
ST Elevation Myocardial Infarction / drug therapy*
ST Elevation Myocardial Infarction / therapy
Shock, Cardiogenic / chemically induced*

Substances

Adrenergic beta-Antagonists
Carbazoles
Propanolamines
Carvedilol